Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation TCT 2025

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

Presenter: Kotaro Higuchi

October 27, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

Yael L. Maxwell

July 11, 2025

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Conference News SCCT 2023

Population Screening for Coronary Plaque: Is the Evidence Enough?

Todd Neale

July 31, 2023

News Daily News

Novel Machine-Learning Score Can Predict FFR-Defined Ischemia Better Than Visual Stenosis

Yael L. Maxwell

October 25, 2022

News Daily News

Higher Physical Activity Linked With CAC Progression

Yael L. Maxwell

September 21, 2021

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

News Daily News

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

L.A. McKeown

January 04, 2021

News Daily News

Coronary Calcium in COVID-19 Patients Linked to Worse Outcomes

Yael L. Maxwell

July 30, 2020

News Daily News

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

Michael O'Riordan

January 24, 2020

News Conference News SCCT 2019

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Yael L. Maxwell

July 23, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Industry News

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

August 08, 2017

News Daily News

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Yael L. Maxwell

June 29, 2017

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

September 20, 2016

News Daily News

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

Leah Lawrence

August 22, 2016

News Industry News

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

July 11, 2016

Advertisement

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

October 2025 Dispatch for the CV Team

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Less Is More: Lp(a) Much More Atherogenic Than LDL

Population Screening for Coronary Plaque: Is the Evidence Enough?

Novel Machine-Learning Score Can Predict FFR-Defined Ischemia Better Than Visual Stenosis

Higher Physical Activity Linked With CAC Progression

Statins Positively Alter Coronary Plaque Composition

Web-Like Structures in COVID-19 STEMI Clots May Offer New Drug Target

Coronary Calcium in COVID-19 Patients Linked to Worse Outcomes

‘Super-Dense’ Calcified Plaque Appears Protective Against ACS

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Atherosclerosis Features Differ Among Male Athletes From Different Sports

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis

FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content